07:00 , Aug 15, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Huntington's disease (HD) NMDA receptor NR3A subtype (GRIN3A; NR3A); huntingtin (HTT) Patient and mouse studies suggest inhibiting...
07:00 , Apr 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology ...